MESOCOLIC: Mesenteric excision surgery or conservative limited resection in Crohn's disease

Trial Overview

AcronymMESOCOLIC trial
NumberNCT03769922
Protocol Linkhttps://pubmed.ncbi.nlm.nih.gov/32085793/
Public Trial Registry Linkclinicaltrials.gov NCT03769922
Published Results LinkNot yet
StatusOpen/recruiting
CategoryIBD
Treatment CourseSurgery

Trial Description

Traditionally, surgical resection for Crohn's disease differs from oncological principles and the mesentery is preserved. This study sought to examine whether resection of the mesentery en bloc in suitable patients reduces post-operative recurrence. The primary endpoint is surgical recurrence. Secondary endpoints include endoscopic and clinical recurrence. This is a multi-centre study between Ireland, USA and China.

Chief Investigator

Calvin Coffey
Professor
Profile Link

Lead Centre

Weiming Zhu
Center for Inflammatory Bowel Diseases, Department of General Surgery,
Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China
NA
China
Website

Collaboration and Funding

Funding Sponsors

Additional Information

Full Research Summary
ESCP Affiliates